Provided is a wearable medical device that includes a processor or logic circuitry. The wearable medical device may include a memory storing instructions that, when executed by the processor or logic circuitry, configure the wearable medical device to determine, by the processor or the logic circuitry, that an event affecting a blood glucose measurement value trend of a user has occurred. Based on the occurrence of the event, the processor or the logic circuitry may select a mode of operation of the analyte sensor, and generate a signal indicating the selected mode of operation. The mode of operation may correspond to a sampling frequency of a physical attribute or physiological condition of a user of the wearable medical device.

A measurement system comprising: a first measurement apparatus including at least a first processor; and a second measurement apparatus including at least a second processor, wherein the first processor and the second processor are configured to measure biological information of a user by synchronizing a timing with each other.

A sensor (110), a sensor assembly (256) for detecting at least one analyte in a body fluid and methods of manufacturing a sensor (110) and a sensor assembly (256) for detecting at least one analyte in a body fluid are disclosed. The sensor (110) has at least one substrate (114). The sensor (110) further has at least two electrodes (116) applied to the substrate (114), wherein the electrodes (116) are adapted for detecting the analyte. The sensor (110) further has at least two contact pads (118) applied to the substrate (114) and at least two electrical traces (120) applied to the substrate (114). The electrical traces (120) electrically connect the electrodes (116) and the contact pads (118). The sensor (110) further comprises a sealing ring (134) fixedly applied to the substrate (114). The sealing ring (134) surrounds the contact pads (118).

Disclosed is a system (100) and method (200) for 12-lead ECG recording and wireless remote monitoring. The system (100) provides a wearable ECG acquisition unit (40) recording 12-lead ECG from torso positions of electrode sensors on user's body thereby permitting unrestrained free movement during recording without compromising on accuracy achieved by conventional 12-lead ECG system. Thus, the system (100) and method (200) provides a reliable, quick to deploy, cost effective and portable alternative to bulky conventional 12-lead ECG systems and eliminates need for resorting to skilled physician every time the 12-lead ECG is to be recorded. The system (100) and method (200) is universal in use and torso placement positions, facilitating uniform acquisition of the 12-lead ECG without altering the placement positions of the electrode sensors irrespective of ECG modalities, thereby serving as a standard format for ECG recording and long term ECG monitoring.

An optical sensing module suitable for wearable devices, the optical sensing module comprising: a silicon or silicon nitride transmitter photonic integrated circuit (PIC), the transmitter PIC comprising: a plurality of lasers, each laser of the plurality of lasers operating at a wavelength that is different from the wavelength of the others; an optical manipulation region, the optical manipulation region comprising one or more of: an optical modulator, optical multiplexer (MUX); and additional optical manipulation elements; and one or more optical outputs for light originating from the plurality of lasers.

An analyte sensor system may include a first communication circuit configured to transmit a wireless signal in a first communication mode and a second communication mode, and a processor, wherein the processor determines whether a first condition is satisfied, the first condition relating to the sensor signal or to communication by the first communication circuit, and shifts the system to a second communication mode responsive to the first condition being satisfied.

A device for calculating a therapeutic remedy result, the device including a display; a sensor; and a computing device in communication with the display and the sensor, wherein the computing device is configured to record a user vibrancy datum; identify a therapeutic remedy instruction set as a function of the user vibrancy datum, wherein the therapeutic remedy instruction set comprises a therapeutic remedy; and calculate a therapeutic remedy result that associates the user vibrancy datum and the therapeutic remedy with a therapy response curve.

Systems and methods for graph total variation (GTV) based reconstruction of electrical potentials on a cardiac surface are disclosed. GTV-based systems and methods incorporate information about the graph structure of the heart surface as well as imposing sparsity constraints on neighboring nodes. To this end, the present disclosure uses a novel way of calculating derivatives on irregular meshes, and provides a fast solver to compute an inverse solution more efficiently than in previous systems and methods. Moreover, fast-changing signals can be recovered with less smoothing and thus greater fidelity to the original signals.

A method and system to seamlessly pair a user to an article includes matching their respective inertial profile. The system comprises of a user sensor that can capture and communicate the motion profile of the user or a part of the user as well as an article sensor that can capture and communicate the motion profile of the article. Both motion profiles are communicated to a pattern matching module. When the article and the user are spatially interacting for at least a minimum period of time, the pattern matching module can determine the level of similarity between the respective profiles. A decision to pair the article to the user is produced based on said level of said profiles similarity.

A system and method for measuring the effectiveness of a dose from an inhaler on a user is disclosed. The inhaler includes a drug container and a dosing mechanism coupled to the drug container to aerate a dose from the drug container. The dosing mechanism provides the aerated dose to the user. A sensor interface is in communication with a physiological sensor. The physiological sensor is attached to a user to sense a physiological response to the dose. Physiological data is sent to the sensor interface. A controller is coupled to the sensor interface to collect the sensed physiological data from the user corresponding to the time that the aerated dose is delivered to the user. The effectiveness of the dose may be determined from the collected data. The dose amount or frequency may be changed or the drug may be changed based on the collected data.